Results 131 to 140 of about 25,648 (169)

HASH(0x563d43feb630) [PDF]

, 2017
Blagojevic, S., Petersen, P., Wild, C.
core  

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies. [PDF]

J Hematol Oncol
Chong SJF, Valentin R, Wang J, Zhu F, Gokhale PC, Eschle BK, Garbicz F, Iskandar K, Sewastianik T, Toh BCY, Penailillo J, Peluso MO, Zhang J, Hackett L, Collins MC, Lehmberg TZ, Adam A, Zhang L, Armet CM, Rausch M, Lee BH, Holland PM, Palombella VJ, Paterson AM, Kong LR, Ten Hacken E, Guerriero JL, Herbaux C, Wu CJ, Chng WJ, Pervaiz S, Niemann CU, Carrasco RD, Davids MS.   +33 more
europepmc   +1 more source

Real-World Analysis of Outcomes of Venetoclax+Azacitidine Versus 7+3 Induction in Acute Myeloid Leukemia. [PDF]

EJHaem
Guevara Rodriguez N, Mercado NC, Kamal SAF, Beesabathina S, Foster D, Rajeh N, Kunwor R.   +6 more
europepmc   +1 more source

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia. [PDF]

Blood Adv
Short NJ, Kantarjian H, Jain N, Kadia TM, Senapati J, Haddad FG, Maroun MM, Sasaki K, Xiao L, Huang X, Karrar O, Abramova R, Zhao M, Garris R, Konopleva M, Ravandi F, Jabbour E.   +16 more
europepmc   +1 more source

FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. [PDF]

Cell Death Dis
Raghuwanshi S, Gartel AL.
europepmc   +1 more source

Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives. [PDF]

Oncol Res
Chen T, Kim G, Rahimi Y, Kamdar M, Fernandez-Hernandez E, Woan K, Tam EL, Yaghmour G.   +7 more
europepmc   +1 more source

Acute Acalculous Cholecystitis Mimicry: Symptomatic Hepatic Infiltration From Chronic Lymphocytic Leukemia Presenting as Cholestatic Liver Injury. [PDF]

ACG Case Rep J
Alnounou A, Zou H, Boamah H.
europepmc   +1 more source

Robust predictors for drug response of patients with acute myeloid leukemia. [PDF]

PLoS One
Tercan B.
europepmc   +1 more source

Is CLL curable? [PDF]

Hemasphere
Jain N, Ferrajoli A, O'Brien S, Wierda W.   +3 more
europepmc   +1 more source